These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21786573)

  • 41. [The interferon inducer neovir (kamedon) in the combined treatment of chronic inflammatory diseases of the adnexa uteri of chlamydial etiology (a clinical electron-microscopic study)].
    Delektorskiĭ VV; Malinovskaia VV; Strizhakov AN; Iashkova GN; Kagramanova ZhA; Genkin DD; Parfenov VV; Galiautdinov DSh; Balandin AN; Lebedeva TV
    Antibiot Khimioter; 1995 May; 40(5):42-7. PubMed ID: 8534181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [INFLUENCE OF REAMBERIN® AND CYCLOFERON® ON CONCETRATION OF "AVERAGE MOLECULES" IN SERUM OF PATIENTS WITH RECCURENT DEPRESSIVE DISORDERS IN OUTPATIENT OBSERVATION].
    Tereshina IF; Kut'ko II; Rachkauskas GS
    Lik Sprava; 2014; (7-8):93-8. PubMed ID: 26118092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of the combination of cycloferon and reamberin in treatment of resistant patients with paranoid schizophrenia].
    Maruta NA; Rachkauskas GS; Frolov VM; Tereshina IF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):36-9. PubMed ID: 22433807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Aproaches to immunotherapy in different immunophenotypes of cutaneous basal cell carcinoma].
    Petrunin DD; Okovityĭ SV; Kostalevskaia AV; Suchkov SV
    Vopr Onkol; 2012; 58(3):406-12, 415. PubMed ID: 22888660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results].
    Romantsov MG; Sologub TV; Shul'diakov AA; Goriacheva LG; Lin'kova IuN; Kovalenko AL
    Eksp Klin Farmakol; 2010 Nov; 73(11):30-3. PubMed ID: 21254596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Up-to-date approach to treatment of inflammatory infections in the maxillofacial region].
    Romantsov MG; Kovalevskiĭ MA; Iaremenko AI; Grigorian SS; Kovalenko AL
    Antibiot Khimioter; 2009; 54(3-4):52-7. PubMed ID: 19711852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The treatment of laryngeal papillomatosis with interferon inducers].
    Karimova FS; Ivanchenko GF; Grigorian SS
    Vestn Otorinolaringol; 2000; (5):54-7. PubMed ID: 11051860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunotropic agents in therapy of chronic degenerative diseases of the vulva].
    Sharapova LE; Shul'diakov AA; Liapina EP
    Antibiot Khimioter; 2012; 57(3-4):25-8. PubMed ID: 22993936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
    Goriacheva LG; Romantsov MG; Agaeva SG; Lin'kov IuN; Kovalenko AL
    Antibiot Khimioter; 2010; 55(5-6):50-7. PubMed ID: 21033475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical efficiency of reamberin - cycloferon combination in treatment of hepatic cirrhosis associated with chronic HCV infection].
    Frolov VM; Sotskaia IaA; Kruglova OV
    Eksp Klin Farmakol; 2012; 75(8):34-8. PubMed ID: 23012994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peculiarities of immunomodulating therapy in an immunocompromised patient with allergies].
    Klin Med (Mosk); 2011; 89(5):60-4. PubMed ID: 22242271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Using cycloferon in the complex treatment of herpetic infection in patients with atopic dermatitis].
    Barkhatova TS; Shul'diakov AA; Gavrilova IB; Sretenskaia DA
    Eksp Klin Farmakol; 2014; 77(3):37-9. PubMed ID: 24800525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of cycloferon in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations].
    Filippova TP; Vasil'eva LS; Kochkin AV
    Ter Arkh; 2010; 82(11):49-53. PubMed ID: 21381350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of therapy with interferon inducer on the parameters of quality of life in patients with pulmonary tuberculosis].
    Demidik SN; Romantsov MG; Smagina AN; Vol'f SB
    Lik Sprava; 2013 Mar; (2):93-8. PubMed ID: 24605618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cycloferon therapy of acute and chronic virus hepatitis C].
    Malyĭ VP; Pen'kov DV; Chiriukina OI
    Antibiot Khimioter; 2013; 58(9-10):34-40. PubMed ID: 24738241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [EFFICACY OF CYCLOFERON LINIMENT IN THE COMBINED TREATMENT OF CHRONIC GINGIVITIS IN PATIENTS WITH CHRONIC INFECTIOUS DISEASES].
    Soboleva LA; Shul'dyakov AA; Bulkina NV
    Eksp Klin Farmakol; 2015; 78(7):41-4. PubMed ID: 26591207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical laboratory approaches to parodontitis treatment optimization].
    Soboleva LA; Shul'diakov AA; Oseeva AO; Aleksandrova EA
    Stomatologiia (Mosk); 2010; 89(6):28-30. PubMed ID: 21311440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses].
    Grigorian SS; Romantsov MG; Demchenko EV; Kovalenko AL
    Eksp Klin Farmakol; 2013; 76(7):39-42. PubMed ID: 24006616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cycloferon: mechanism of action, functions and application].
    Bazhanova ED
    Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [ASSESSMENT OF INDICATORS FOR INTERFERON SYSTEM IN PATIENTS WITH COMMON FORMS OF PULMONARY TUBERCULOSIS RECEIVING COMPLEX THERAPY WITH CYCLOFERON].
    Budritskii AM; Pravada NS
    Eksp Klin Farmakol; 2015; 78(6):15-8. PubMed ID: 26292509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.